OR WAIT null SECS
December 15, 2020
Through the acquisition, Eli Lilly will have access to Prevail’s portfolio of clinical-stage and preclinical neuroscience assets.
Sterling Pharma Solutions has formed a new strategic partnership with ADC Bio.
December 14, 2020
The company will expand the site to include six new containment isolators and a product development manufacturing laboratory.
December 11, 2020
The European Commission has granted a license for the use of inclisiran (Leqvio) as a treatment of primary hypercholesterolemia or mixed dyslipidaemia in adult patients.
Celltrion Healthcare has announced that EMA's CHMP has issued a positive opinion for the marketing authorization of CT-P17—an adalimumab biosimilar.
The Vaccines Manufacturing and Innovation Centre (VMIC) has chosen Lonza’s MODA-EM solution for the digitalization of its microbiology quality control operations.
December 10, 2020
With the acquisition, Evonik will expand its life science division and its portfolio of functional excipients and biomaterials.
Evonik offers lipid nanoparticles for gene-based drug development and manufacturing.
December 09, 2020
The company is investing in expansion at four sites in the United States, United Kingdom, and Italy, which will include construction of new facilities and addition of sterile and lyophilized filling lines.
Cytiva is adding process development, media and assay development, and contract development services at its facilities in Korea, Japan, Sweden, and the UK.